共 50 条
- [21] Clinical efficacy and safety of etanercept plus methotrexate or etanercept alone in rheumatoid arthritis patients with inadequate response to methotrexate: The ADORE studyRHEUMATOLOGY, 2006, 45 : I45 - I45Taggart, A. J.van Riel, P. L. C. M.Reynolds, A.Sany, J.Gaubitz, M.Phillips, C.Pedersen, R.Singh, A.MacPeek, D.
- [22] COMPARATIVE EFFICACY OF BIOLOGICS AS MONOTHERAPY AND IN COMBINATION WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO CONVENTIONAL DMARDS: A NETWORK META-ANALYSISRHEUMATOLOGY, 2013, 52 : 93 - 93Buckley, FelicityFinckh, AxelHuizinga, Tom W.Dejonckheere, FredJansen, Jeroen P.
- [23] Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naive to DMARDs Results from a retrospective cohort studyMEDICINE, 2021, 100 (17) : E25481Floris, AlbertoPerra, DanielaCangemi, IgnazioCongia, MattiaChessa, ElisabettaAngioni, Maria MaddalenaMangoni, Arduino AleksanderErre, Gian LucaMathieu, AlessandroPiga, MatteoCauli, Alberto
- [24] Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE studyANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (11) : 1478 - 1483van Riel, P. L. C. M.Taggart, A. J.Sany, J.Gaubitz, M.Nab, H. W.Pedersen, R.Freundlich, B.MacPeek, D.
- [25] Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexateANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 333 - 340Keystone, Edward C.Taylor, Peter C.Drescher, EditSchlichting, Douglas E.Beattie, Scott D.Berclaz, Pierre-YvesLee, Chin H.Fidelus-Gort, Rosanne K.Luchi, Monica E.Rooney, Terence P.Macias, William L.Genovese, Mark C.
- [26] Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort studyCLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)Nakayama, YoichiOnishi, AkiraYamamoto, WataruYoshikawa, AyakaShiba, HideyukiYoshida, NaofumiSon, YonsuShirasugi, IkuMaeda, ToshihisaKatsushima, MasaoHashimoto, MotomuEtani, YukiItami, TetsuNozaki, YujiOnizawa, HideoFujii, TakayukiMurakami, KosakuMurata, KoichiTanaka, MasaoMatsuda, ShuichiMorinobu, Akio
- [27] Efficacy and Safety of Filgotinib for Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: FINCH 1 Primary Outcome ResultsJOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1108 - 1108Keystone, EdwardCombe, BernardKivitz, AlanTanaka, Yoshiyavan der Heijde, DesireeMatzkies, FranziskaBartok, BeatrixYe, LieGuo, YingTasset, ChantalSundy, JohnMozaffarian, NeelufarLandewe, RobertBae, Sang-CheolNash, Peter
- [28] FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS (BDMARD-IR) BY RACE & GEOGRAPHIC REGIONANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 361 - 361Gottenberg, Jacques-EricGenovese, Mark C.Kalunian, KennethMozaffarian, NeelufarBartok, BeatrixMatzkies, FranziskaGao, JieGuo, YingWalker, DavidTakeuchi, Tsutomude Vlam, Kurt
- [29] A Phase IIb, Randomized, Double-blind Study in Patients with Rheumatoid Arthritis Evaluating the Safety and Efficacy of Evobrutinib Compared with Placebo in Patients with an Inadequate Response to MethotrexateARTHRITIS & RHEUMATOLOGY, 2020, 72Peterfy, CharlesBuch, MayaChoy, ErnestSchett, GeorgParsons-Rich, DanaPatel, AnandZima, YuliaLe Bolay, ClaireGenovese, Mark
- [30] Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumor necrosis factor inhibitors: a systematic review and meta-analysisRHEUMATOLOGY INTERNATIONAL, 2017, 37 (07) : 1053 - 1064Abushouk, Abdelrahman IbrahimAhmed, HussienIsmail, AmmarElmaraezy, AhmedBadr, Ahmed SaidGadelkarim, MohamedElnenny, Mohammed